gsk

Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds

The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in…

3 years ago

NICE turns down GSK’s IV Benlysta for systemic lupus

The National Institute for Health and Care Excellence (NICE) has rejected NHS funding for an intravenous formulation of GlaxoSmithKline's Benlysta…

3 years ago

GlaxoSmith launches trial for Covid-19 vaccine

Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they…

3 years ago

Vaccine candidate from Canada’s Medicago shows strong antibody response to Covid

Canadian drug developer Medicago’s plant-based Covid-19 vaccine candidate, enhanced by a GlaxoSmithKline treatment, was able to create a strong antibody…

3 years ago